Publications [#324786] of David B. Ridley

Journal Articles

1. Ridley, DB, Priorities for the Priority Review Voucher., The American journal of tropical medicine and hygiene, vol. 96 no. 1 (January, 2017), pp. 14-15 [doi]
   (last updated on 2026/01/14)

   Abstract:
   The U.S. Congress created the priority review voucher program in 2007 to encourage development of drugs for neglected diseases. Under the voucher program, the developer of a drug for a neglected or rare pediatric disease that is approved by the U.S. Food and Drug Administration receives a bonus priority review voucher for another drug. As of 2016, four vouchers have sold for an average price of $200 million. Recent experience with the voucher program indicates strengths and weaknesses of the program, as well as a need for legislative changes.